XML 19 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2022
Mar. 31, 2022
Sep. 30, 2021
Mar. 31, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Statement of Cash Flows [Abstract]              
Net loss for the period $ (9,254) $ (14,730) $ (7,957) $ (10,910) $ (42,043) $ (29,658)  
Items not involving cash:              
Depletion, depreciation and amortization 850   800   2,529 2,363  
Share-based compensation         3,292 1,702  
Change in value of warrant liabilities         0 8,050  
Accretion of asset retirement obligation 397   350   1,301 1,022 $ 1,284
Unrealized foreign exchange (gain) loss         2,284 (440)  
Revision and settlement of asset retirement obligation         (238) (39)  
Unrealized gain on available-for-sale assets         13,716 0  
Other non-cash expenses (income)         297 (3,017)  
Changes in assets and liabilities              
(Increase) decrease in inventories         2,729 (1,673)  
(Increase) decrease in trade and other receivables         565 (61)  
Increase in prepaid expenses and other assets         (7,614) (678)  
Decrease in accounts payable and accrued liabilities         (1,703) (434)  
Net cash used in operating activities         (29,453) (21,983)  
INVESTING ACTIVITIES              
Purchase of property, plant and equipment         1,237 953  
Purchases of marketable securities         (11,435) 0  
Maturities and sales of marketable securities         0 2,554  
Net cash (used in) provided by investing activities         (12,672) 1,601  
FINANCING ACTIVITIES              
Issuance of common shares for cash, net of issuance cost         7,886 92,122  
Cash paid to fund employee income tax withholding due upon vesting of restricted stock units         (884) (659)  
Cash received from exercise of stock options         472 1,718  
Cash received from exercise of warrants         0 6,627  
Cash paid to settle and fund employee income tax withholding due upon exercise of stock appreciation rights         (11) (48)  
Cash received from non-controlling interest         0 229  
Net cash provided by financing activities         7,463 99,989  
Effect of exchange rate fluctuations on cash held in foreign currencies         (84) (61)  
Net change in cash, cash equivalents and restricted cash         (34,746) 79,546  
Cash, cash equivalents and restricted cash, beginning of period   $ 132,822   $ 40,985 132,822 40,985 40,985
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, END OF PERIOD $ 98,076   $ 120,531   98,076 120,531 $ 132,822
Supplemental disclosure of cash flow information:              
Increase (decrease) in accrued capital expenditures and accounts payable for property, plant and equipment         $ (116) $ 0